PT Darya-Varia Laboratoria Tbk Stock price

Equities

DVLA

ID1000117203

Pharmaceuticals

End-of-day quote INDONESIA S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
1,460 IDR -2.01% Intraday chart for PT Darya-Varia Laboratoria Tbk +4.66% -12.31%
Sales 2022 1,917B 121M Sales 2023 1,891B 119M Capitalization 1,865B 117M
Net income 2022 149B 9.41M Net income 2023 146B 9.22M EV / Sales 2022 1.2 x
Net cash position 2022 355B 22.37M Net cash position 2023 239B 15.03M EV / Sales 2023 0.86 x
P/E ratio 2022
17.8 x
P/E ratio 2023
12.7 x
Employees 1,271
Yield 2022
5.02%
Yield 2023
-
Free-Float 7.87%
More Fundamentals * Assessed data
Dynamic Chart
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2022 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2020 CI
PT Darya-Varia Laboratoria Tbk Launches New Variant, Natur-E White Series CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2019 CI
More news
1 day-1.65%
1 week+6.81%
Current month-8.59%
1 month-9.42%
3 months-9.70%
6 months-24.94%
Current year-10.51%
More quotes
1 week
1 375.00
Extreme 1375
1 540.00
1 month
1 375.00
Extreme 1375
1 645.00
Current year
1 375.00
Extreme 1375
1 720.00
1 year
1 375.00
Extreme 1375
2 110.00
3 years
1 375.00
Extreme 1375
3 400.00
5 years
1 375.00
Extreme 1375
3 400.00
10 years
1 160.00
Extreme 1160
3 400.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 20-09-30
Director of Finance/CFO 55 22-06-27
Chairman 53 04-12-31
Members of the board TitleAgeSince
Chairman 53 04-12-31
Director/Board Member 62 05-05-31
Director/Board Member 56 19-06-10
More insiders
Date Price Change Volume
24-03-27 1,460 -2.01% 73 200
24-03-27 1,490 -1.65% 126,300
24-03-26 1,515 +0.33% 51,800
24-03-25 1,510 +8.63% 152,200
24-03-22 1,390 0.00% 230,900

End-of-day quote INDONESIA S.E., March 26, 2024

More quotes
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is an Indonesia-based company operating in the pharmaceutical industry. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The Company provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The Company also provides Imunped as supplement for kids with Zinc and vitamin C for children.
More about the company
  1. Stock
  2. Equities
  3. Stock PT Darya-Varia Laboratoria Tbk - INDONESIA S.E.